ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,373, issued on Sept. 30, was assigned to The Broad Institute Inc. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Mass.).

"Dopamine D2 receptor ligands" was invented by Edward Holson (Cambridge, Mass.), Florence Fevrier Wagner (Cambridge, Mass.), Michel Weiwer (Cambridge, Mass.), Edward Scolnick (Cambridge, Mass.), Michelle Palmer (Cambridge, Mass.), Luka Dordevic (Cambridge, Mass.), Michael C. Lewis (Cambridge, Mass.), Jennifer Q. Pan (Cambridge, Mass.), Yan-Ling Zhang (Cambridge, Mass.) and Qihong Xu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel dopamine D2 recepto...